» Articles » PMID: 29326298

Smoking Duration Alone Provides Stronger Risk Estimates of Chronic Obstructive Pulmonary Disease Than Pack-years

Abstract

Background: Cigarette smoking is the strongest risk factor for COPD. Smoking burden is frequently measured in pack-years, but the relative contribution of cigarettes smoked per day versus duration towards the development of structural lung disease, airflow obstruction and functional outcomes is not known.

Methods: We analysed cross-sectional data from a large multicentre cohort (COPDGene) of current and former smokers. Primary outcome was airflow obstruction (FEV/FVC); secondary outcomes included five additional measures of disease: FEV, CT emphysema, CT gas trapping, functional capacity (6 min walk distance, 6MWD) and respiratory morbidity (St George's Respiratory Questionnaire, SGRQ). Generalised linear models were estimated to compare the relative contribution of each smoking variable with the outcomes, after adjustment for age, race, sex, body mass index, CT scanner, centre, age of smoking onset and current smoking status. We also estimated adjusted means of each outcome by categories of pack-years and combined groups of categorised smoking duration and cigarettes/day, and estimated linear trends of adjusted means for each outcome by categorised cigarettes/day, smoking duration and pack-years.

Results: 10 187 subjects were included. For FEV/FVC, standardised beta coefficient for smoking duration was greater than for cigarettes/day and pack-years (P<0.001). After categorisation, there was a linear increase in adjusted means FEV/FVC with increase in pack-years (regression coefficient β=-0.023±SE0.003; P=0.003) and duration over all ranges of smoking cigarettes/day (β=-0.041±0.004; P<0.001) but a relatively flat slope for cigarettes/day across all ranges of smoking duration (β=-0.009±0.0.009; P=0.34). Strength of association of duration was similarly greater than pack-years for emphysema, gas trapping, FEV, 6MWD and SGRQ.

Conclusion: Smoking duration alone provides stronger risk estimates of COPD than the composite index of pack-years.

Trial Registration Number: Post-results; NCT00608764.

Citing Articles

Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma.

Lam A, Hueniken K, Pienkowski M, Lee J, Dong M, Diergaarde B JAMA Otolaryngol Head Neck Surg. 2025; .

PMID: 39976935 PMC: 11843462. DOI: 10.1001/jamaoto.2024.5392.


Effect of Mind Sound Resonance Technique on Pulmonary Function and Smoking Behavior among Smokers - A Prospective Randomized Control Trial.

Girishankara K, Shetty S, Ramaswamy K, Shetty P Int J Yoga. 2025; 17(3):222-231.

PMID: 39959505 PMC: 11823559. DOI: 10.4103/ijoy.ijoy_117_24.


Association of e-cigarette and cigarette use with self-reported chronic obstructive pulmonary disease (COPD): a multivariable analysis of a large United States data set.

Burns A, Steinberg A, Sargent J, Ozga J, Tang Z, Stanton C Respir Res. 2025; 26(1):49.

PMID: 39920672 PMC: 11806618. DOI: 10.1186/s12931-024-03087-4.


The global burden of chronic respiratory diseases attributable to tobacco from 1990 to 2021: a global burden of disease study 2021.

Feng H, Li Z, Zheng R BMC Public Health. 2025; 25(1):456.

PMID: 39905394 PMC: 11796058. DOI: 10.1186/s12889-025-21680-0.


Risk of all-cause mortality by various cigarette smoking indices: A longitudinal study using the Korea National Health Examination Baseline Cohort in South Korea.

Kang H, Cheon E, Hwang J, Jo S, Na K, Park S Tob Induc Dis. 2025; 23.

PMID: 39877382 PMC: 11773640. DOI: 10.18332/tid/199670.


References
1.
Tashkin D, Altose M, Connett J, Kanner R, Lee W, Wise R . Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1996; 153(6 Pt 1):1802-11. DOI: 10.1164/ajrccm.153.6.8665038. View

2.
Etter J, Perneger T . Measurement of self reported active exposure to cigarette smoke. J Epidemiol Community Health. 2001; 55(9):674-80. PMC: 1731967. DOI: 10.1136/jech.55.9.674. View

3.
Anthonisen N, Connett J, Murray R . Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002; 166(5):675-9. DOI: 10.1164/rccm.2112096. View

4.
. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

5.
Scherer G . Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl). 1999; 145(1):1-20. DOI: 10.1007/s002130051027. View